Literature DB >> 2896013

Exercise haemodynamics and maximal exercise capacity during beta-adrenoceptor blockade in normotensive and hypertensive subjects.

M A van Baak1, F M Koene, F T Verstappen.   

Abstract

1. The effects of atenolol administration on maximal exercise capacity and exercise haemodynamics have been compared in eight normotensive and eight mildly hypertensive subjects, matched for sex, age, body weight, and maximal oxygen uptake, and familiar with maximal exercise testing. 2. Supine and exercise blood pressure, and exercise total peripheral resistance were significantly higher, and exercise cardiac output was significantly lower in the hypertensive than in the normotensive subjects. 3. Administration of atenolol (1 X 100 mg day-1) for 3 days reduced supine and exercise systolic blood pressure, heart rate, and cardiac output, and increased exercise stroke volume. Supine and exercise diastolic blood pressure and exercise total peripheral resistance were unaffected by atenolol. The effects of atenolol did not differ in the normotensive and the hypertensive subjects. 4. Maximal work load, maximal oxygen uptake, and maximal heart rate were reduced to a similar extent in normotensive and hypertensive subjects during atenolol treatment. 5. It is concluded that there is no difference in the effects of short-term atenolol administration on exercise haemodynamics and maximal exercise capacity in normotensive and mildly hypertensive subjects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896013      PMCID: PMC1386471          DOI: 10.1111/j.1365-2125.1988.tb03288.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  29 in total

1.  Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.

Authors:  M A van Baak; F T Verstappen; B Oosterhuis
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 2.  [Ergometry--recommendations for the execution and evaluation of ergometric studies].

Authors: 
Journal:  Klin Wochenschr       Date:  1985-07-15

3.  Metabolic effects in muscle during antihypertensive therapy with beta 1- and beta 1/beta 2-adrenoceptor blockers.

Authors:  M Frisk-Holmberg; L Jorfeldt; A Juhlin-Dannfelt
Journal:  Clin Pharmacol Ther       Date:  1981-11       Impact factor: 6.875

4.  Effects of cardioselective and nonselective beta-blockade on dynamic exercise performance in mildly hypertensive men.

Authors:  F H Leenen; C H Coenen; M Zonderland; A H Maas
Journal:  Clin Pharmacol Ther       Date:  1980-07       Impact factor: 6.875

5.  The effects of beta-adrenoceptor blockade on renin, angiotensin, aldosterone and catecholamines at rest and during exercise.

Authors:  P J Lijnen; A K Amery; R H Fagard; T M Reybrouck; E J Moerman; A F De Schaepdryver
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

6.  Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol.

Authors:  H Folgering; M van Bussel
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

7.  Effect of beta 1-selective and non-selective beta-blockade on work capacity and muscle metabolism.

Authors:  P Kaiser; P A Tesch; M Frisk-Holmberg; A Juhlin-Dannfelt; L Kaijser
Journal:  Clin Physiol       Date:  1986-04

8.  Hemodynamic response to graded exercise after chronic beta-adrenergic blockade.

Authors:  T Reybrouck; A Amery; L Billiet
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-02

9.  Effect of oral propranolol on the anerobic threshold and maximum exercise performance in normal man.

Authors:  R L Hughson; B J MacFarlane
Journal:  Can J Physiol Pharmacol       Date:  1981-06       Impact factor: 2.273

10.  Effects of beta-adrenergic blockade on O2 uptake during submaximal and maximal exercise.

Authors:  P A Tesch; P Kaiser
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-04
View more
  7 in total

1.  Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.

Authors:  S H Thomas; R C Cooper; M Ekwuru; S Fletcher; J Gilbody; T S Husseyin; M Ishaque; R Jagathesan; G Reddy; S E Smith
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Beta-adrenoceptor blockade and exercise. An update.

Authors:  M A Van Baak
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

3.  Chronic beta-blockade does not influence muscle power output during high-intensity exercise of short-duration.

Authors:  W E Derman; F Dunbar; M Haus; M Lambert; T D Noakes
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

4.  Differential effects of beta-adrenoreceptor antagonists on central and peripheral blood pressure at rest and during exercise.

Authors:  James A Cockburn; Sally E Brett; Antoine Guilcher; Albert Ferro; James M Ritter; Philip J Chowienczyk
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

5.  Exercise tolerance with nebivolol and atenolol.

Authors:  L M Van Bortel; M A van Baak
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 6.  Rational use of antihypertensive medications in children.

Authors:  Michael A Ferguson; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2013-05-29       Impact factor: 3.714

7.  Exercise performance during captopril and atenolol treatment in hypertensive patients.

Authors:  M A Van Baak; F M Koene; F T Verstappen; E S Tan
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.